Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001178913-25-001262
Filing Date
2025-04-10
Accepted
2025-04-10 16:06:15
Documents
21

Document Format Files

Seq Description Document Type Size
1 POS AM zk2532996.htm POS AM 2620127
2 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 5600
3 image0.jpg GRAPHIC 394107
4 image1.jpg GRAPHIC 636481
5 image2.jpg GRAPHIC 719455
6 image3.jpg GRAPHIC 295021
7 image4.jpg GRAPHIC 317535
8 image5.jpg GRAPHIC 677603
9 image6.jpg GRAPHIC 1083096
10 image7.jpg GRAPHIC 370237
11 image8.jpg GRAPHIC 226954
12 image9.jpg GRAPHIC 309343
13 image10.jpg GRAPHIC 253099
14 image11.jpg GRAPHIC 500552
15 image12.jpg GRAPHIC 325749
16 image13.jpg GRAPHIC 527807
17 image14.jpg GRAPHIC 246927
18 image15.jpg GRAPHIC 302097
19 image16.jpg GRAPHIC 204592
20 image17.jpg GRAPHIC 218158
21 image00018.jpg GRAPHIC 38245
  Complete submission text file 0001178913-25-001262.txt   13159729
Mailing Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606
Business Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606 972-8-6286005
Silexion Therapeutics Corp (Filer) CIK: 0002022416 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-282017 | Film No.: 25828386
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)